Insufficient scRNA-seq data for expression of FUT4 at single-cell level.
Insufficient scRNA-seq data for expression of FUT4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 100% | 885.39 | 358 / 359 | 100% | 27.42 | 285 / 286 |
intestine | 100% | 974.72 | 965 / 966 | 99% | 29.15 | 521 / 527 |
pancreas | 100% | 791.69 | 328 / 328 | 94% | 10.88 | 167 / 178 |
lung | 99% | 523.86 | 575 / 578 | 87% | 6.81 | 1010 / 1155 |
esophagus | 99% | 424.16 | 1434 / 1445 | 84% | 18.54 | 154 / 183 |
kidney | 100% | 398.31 | 89 / 89 | 82% | 4.41 | 736 / 901 |
prostate | 99% | 349.49 | 243 / 245 | 77% | 2.45 | 386 / 502 |
breast | 100% | 468.15 | 459 / 459 | 71% | 2.80 | 791 / 1118 |
bladder | 100% | 475.90 | 21 / 21 | 67% | 8.76 | 338 / 504 |
uterus | 99% | 537.04 | 169 / 170 | 60% | 3.70 | 277 / 459 |
skin | 86% | 385.86 | 1554 / 1809 | 67% | 2.65 | 317 / 472 |
ovary | 100% | 464.63 | 180 / 180 | 50% | 1.59 | 214 / 430 |
thymus | 99% | 313.72 | 648 / 653 | 49% | 1.93 | 298 / 605 |
brain | 92% | 197.73 | 2428 / 2642 | 53% | 1.79 | 375 / 705 |
liver | 82% | 160.81 | 186 / 226 | 34% | 3.20 | 139 / 406 |
adrenal gland | 97% | 229.31 | 250 / 258 | 17% | 0.50 | 40 / 230 |
adipose | 100% | 534.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 734.03 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 500.31 | 1328 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 659.01 | 909 / 929 | 0% | 0 | 0 / 0 |
heart | 91% | 219.16 | 781 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 4.51 | 24 / 29 |
tonsil | 0% | 0 | 0 / 0 | 71% | 2.96 | 32 / 45 |
muscle | 53% | 72.58 | 426 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 18% | 0.42 | 14 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006954 | Biological process | inflammatory response |
GO_0009312 | Biological process | oligosaccharide biosynthetic process |
GO_1903037 | Biological process | regulation of leukocyte cell-cell adhesion |
GO_0036065 | Biological process | fucosylation |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0097022 | Biological process | lymphocyte migration into lymph node |
GO_0042355 | Biological process | L-fucose catabolic process |
GO_1903238 | Biological process | positive regulation of leukocyte tethering or rolling |
GO_1902624 | Biological process | positive regulation of neutrophil migration |
GO_0009311 | Biological process | oligosaccharide metabolic process |
GO_0006486 | Biological process | protein glycosylation |
GO_0016020 | Cellular component | membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0009986 | Cellular component | cell surface |
GO_0000139 | Cellular component | Golgi membrane |
GO_0071944 | Cellular component | cell periphery |
GO_0032580 | Cellular component | Golgi cisterna membrane |
GO_0008417 | Molecular function | fucosyltransferase activity |
GO_0017083 | Molecular function | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO_0046920 | Molecular function | alpha-(1->3)-fucosyltransferase activity |
Gene name | FUT4 |
Protein name | Alpha-(1,3)-fucosyltransferase 4 (4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase) (EC 2.4.1.152) (ELAM-1 ligand fucosyltransferase) (Fucosyltransferase 4) (Fucosyltransferase IV) (Fuc-TIV) (FucT-IV) (Galactoside 3-L-fucosyltransferase) |
Synonyms | FCT3A ELFT |
Description | FUNCTION: [Isoform Short]: Catalyzes alpha(1->3) linkage of fucosyl moiety transferred from GDP-beta-L-fucose to N-acetyl glucosamine (GlcNAc) within type 2 lactosamine (LacNAc, Gal-beta(1->4)GlcNAc) glycan attached to N- or O-linked glycoproteins . Robustly fucosylates nonsialylated distal LacNAc unit of the polylactosamine chain to form Lewis X antigen (CD15), a glycan determinant known to mediate important cellular functions in development and immunity. Fucosylates with lower efficiency sialylated LacNAc acceptors to form sialyl Lewis X and 6-sulfo sialyl Lewis X determinants that serve as recognition epitopes for C-type lectins . Together with FUT7 contributes to SELE, SELL and SELP selectin ligand biosynthesis and selectin-dependent lymphocyte homing, leukocyte migration and blood leukocyte homeostasis (By similarity). In a cell type specific manner, may also fucosylate the internal LacNAc unit of the polylactosamine chain to form VIM-2 antigen that serves as recognition epitope for SELE . .; FUNCTION: [Isoform Long]: Does not generate Lewis X antigens. . |
Accessions | ENST00000358752.4 [P22083-1] P22083 |